People in the United States still struggle to access sexual and reproductive health care, as evidenced by the unintended pregnancy rate of 45%.

Ashley H. Meredith, PharmD, MPH, BCACP, BCPS, CDCES, FCCP

Legislative, legal, and regulatory developments affecting pharmacy in 2022

Jason S. Haney, PharmD, BCPS, BCCCP

Four new therapeutic agents are considered in this review, the first in a series of articles on new therapeutic agents marketed in 2022: tirzepatide (Mounjaro–Eli Lilly and Company), daridorexant hydrochloride (Quviviq–Idorsia), tenapanor hydrochloride (Ibsrela–Ardelyx), and vonoprazan fumarate in co-packaging with amoxicillin, and amoxicillin and clarithromycin (Voquezna–Phathom Pharmaceuticals).